Avanscure Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.54 M
as on 08-12-2024
- Revenue 59.00%
(FY 2022)
- Profit 90.41%
(FY 2022)
- Ebitda 3611.72%
(FY 2022)
- Net Worth 40.10%
(FY 2022)
- Total Assets 12.66%
(FY 2022)
About Avanscure Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.54 M.
Gagan Singh and Madan Singh serve as directors at the Company.
- CIN/LLPIN
U74120UP2012PTC050329
- Company No.
050329
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Avanscure Lifesciences Private Limited offer?
Avanscure Lifesciences Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Feed Additives, Nutraceuticals & Dietary Supplements, Mineral Supplement, Ayurvedic & Herbal Extracts, Herbal Extracts, Nutraceuticals, Flavours & Aromatics, Food Enzymes, Bakery & Confectionery Flavors.
Who are the key members and board of directors at Avanscure Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gagan Singh  | Director | 07-May-2012 | Current |
| Madan Singh | Director | 07-May-2012 | Current |
Financial Performance of Avanscure Lifesciences.
Avanscure Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59% increase. The company also saw a substantial improvement in profitability, with a 90.41% increase in profit. The company's net worth Soared by an impressive increase of 40.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avanscure Lifesciences?
Unlock access to Avanscure Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jun 2024 | ₹2.54 M | Open |
How Many Employees Work at Avanscure Lifesciences?
Unlock and access historical data on people associated with Avanscure Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avanscure Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avanscure Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
